1. Signaling Pathways
  2. Immunology/Inflammation
  3. Thrombopoietin Receptor

Thrombopoietin Receptor (血小板生成素受体)

Thrombopoietin (TPO) is the major regulator of megakaryocytopoiesis and platelet formation. The protein encoded by the c-mpl gene, CD110, is a 635 amino acid transmembrane domain, with two extracellular cytokine receptor domains and two intracellular cytokine receptor box motifs. Upon binding of thrombopoietin CD110 is dimerized and the JAK family of non-receptor tyrosine kinases, as well as the STAT family, the MAPK family, the adaptor protein Shc and the receptors themselves become tyrosine phosphorylated.

TPO binds to the thrombopoietin receptor (TPOr, also termed c-mpl) on platelets, megakaryocytes, and pluripotent stem cells leading to inhibition of apoptosis of stem cells and megakaryocytes; increased megakaryocyte number, size, and ploidy; increased rate of megakaryocyte maturation and platelet count; and decreased platelet threshold for activation by ADP and collagen.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-13463R
    Avatrombopag (Standard) Agonist
    Avatrombopag (Standard)是 Avatrombopag 的分析标准品。本产品用于研究及分析应用。Avatrombopag (AKR-501) 是一种口服活性的非肽血小板生成素受体 (TPO receptor)激动剂 (EC50=3.3 nM)。Avatrombopag 可模拟 TPO 的生物活性。Avatrombopag hydrochloride 通过激活细胞内信号传导系统来增加血小板的产生,并促进造血前体细胞产生血小板和巨核细胞。Avatrombopag是细胞色素 P450 (CYP) 2C9 和 CYP3A 的底物。
    Avatrombopag (Standard)
  • HY-19883R
    Lusutrombopag (Standard)

    芦曲泊帕(Standard)

    Agonist
    Lusutrombopag (Standard)是 Lusutrombopag 的分析标准品。本产品用于研究及分析应用。Lusutrombopag 是一种可口服的血小板生成素受体 (thrombopoietin receptor) 激动剂,有潜力用于慢性肝病的研究。
    Lusutrombopag (Standard)
目录号 产品名 / 同用名 种属 表达系统
目录号 产品名 / 同用名 应用 反应物种